Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELTP
$0.25
+1.02%
ELTP
· Elite Pharmaceuticals Inc
$0.25
+0.00 (+1.02%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$269.28M
Shares
1.08B
Volume · Oct 22
258.92K
Avg daily vol (3M)
772.21K
All webcasts
Earnings call · FY2025 Q1
Elite Pharmaceuticals Inc (ELTP) Q1 2025 Earnings Call
Revenue
$18.80M
+109.4% YoY
Diluted EPS
$0.00
Gross margin
45.1%
-7.8 pp YoY
Net income
$615,773
-46.1% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 1, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2024 · complete as-filed document